WellCare Health Plans – The health insurer earned an adjusted $4.31 per share for the second quarter, beating the $4.16 a share consensus estimate. Revenue also came in above forecasts and WellCare said it is in the process of pursuing regulatory approvals for its deal to buy rival Centene. The company is not providing forward guidance due to the pending transaction.